InvestorsHub Logo
Followers 7
Posts 585
Boards Moderated 0
Alias Born 08/25/2012

Re: Hike post# 203907

Friday, 07/26/2019 10:19:52 AM

Friday, July 26, 2019 10:19:52 AM

Post# of 426540
AstraZeneca STRENGTH trial (Epanova) just updated and completion pushed back again. This time to Sept 2020 with readout some time after. (A big delay is not usually indicative of a strong positive outcome)

Epanova is a reformulated Lovaza with EPA/DHA and does a good job of lowering triglycerides. The CVOT outcome is a different animal and back in 2013 the FDA wouldn't approve the Vascepa label because of so much data showing EPA/DHA has not shown to improve CVOT outcomes.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News